| 1 |
34671871 | Pirfenidone as a novel cardiac protective treatment. | 2022 Mar |
3 |
| 2 |
33880743 | Role of pirfenidone in TGF-β pathways and other inflammatory pathways in acute respiratory syndrome coronavirus 2 (SARS-Cov-2) infection: a theoretical perspective. | 2021 Jun |
1 |
| 3 |
32482058 | Combination Therapy With Polydeoxyribonucleotide and Pirfenidone Alleviates Symptoms of Acute Respiratory Distress Syndrome in Human Lung Epithelial A549 Cells. | 2020 May |
1 |
| 4 |
32638026 | Pirfenidone reduces immune-suppressive capacity of cancer-associated fibroblasts through targeting CCL17 and TNF-beta. | 2020 Jul 10 |
1 |
| 5 |
33042971 | Use of the Reversible Myogenic to Lipogenic Transdifferentiation Switch for the Design of Pre-clinical Drug Screening in Idiopathic Pulmonary Fibrosis. | 2020 |
1 |
| 6 |
33364960 | Potential Targeting of Renal Fibrosis in Diabetic Kidney Disease Using MicroRNAs. | 2020 |
1 |
| 7 |
28921394 | Combination Therapy with Pirfenidone plus Prednisolone Ameliorates Paraquat-Induced Pulmonary Fibrosis. | 2018 Feb |
1 |
| 8 |
26640402 | Role and New Insights of Pirfenidone in Fibrotic Diseases. | 2015 |
2 |
| 9 |
24270813 | CX3CL1 (fractalkine) and TNFα production by perfused human placental lobules under normoxic and hypoxic conditions in vitro: the importance of CX3CR1 signaling. | 2014 Mar |
1 |
| 10 |
24711695 | Efficacy and safety of pirfenidone for idiopathic pulmonary fibrosis. | 2014 |
1 |
| 11 |
25064094 | Treatment with pirfenidone for two years decreases fibrosis, cytokine levels and enhances CB2 gene expression in patients with chronic hepatitis C. | 2014 Jul 27 |
2 |
| 12 |
20683502 | Pirfenidone in idiopathic pulmonary fibrosis. | 2010 Jul |
1 |
| 13 |
18387510 | Effects of three anti-TNF-alpha drugs: etanercept, infliximab and pirfenidone on release of TNF-alpha in medium and TNF-alpha associated with the cell in vitro. | 2008 May |
4 |
| 14 |
11724446 | Pirfenidone for chronic progressive multiple sclerosis. | 2001 Oct |
4 |